Brian C Helsel1, Joel E Williams2, Kristen Lawson3, Jessica Liang4, Jonathan Markowitz5. 1. Department of Public Health Sciences, Clemson University, P.O. Box 340745, Clemson, SC, 29634-0745, USA. bhelsel@clemson.edu. 2. Department of Public Health Sciences, Clemson University, P.O. Box 340745, Clemson, SC, 29634-0745, USA. 3. Department of Nursing, Clemson University, Clemson, SC, USA. 4. Department of Healthcare Leadership and Management, Medical University of South Carolina, Charleston, SC, USA. 5. Department of Pediatric Gastroenterology, Greenville Health System, Greenville, SC, USA.
Abstract
BACKGROUND: Mobile applications and interactive websites are an increasingly used method of telemedicine, but their use lacks evidence in digestive diseases. AIM: This study aims to explore digestive disease studies that use telemedicine to effectively manage disease activity, help monitor symptoms, improve compliance to the treatment protocol, increase patient satisfaction, and enhance the patient-to-provider communication. METHODS: EBSCO, PubMed, and Web of Science databases were searched using Medical Subject Headings and other keywords to identify studies that utilized telemedicine in patients with digestive disease. The PRISMA guidelines were used to identify 20 research articles that had data aligning with 4 common overlapping themes including, patient compliance (n = 13), patient satisfaction (n = 11), disease activity (n = 15), and quality of life (n = 13). The studies focused on digestive diseases including inflammatory bowel disease (n = 7), ulcerative colitis (n = 4), Crohn's Disease (n = 1), irritable bowel syndrome (n = 6), and colorectal cancer (n = 2). RESULTS: From the studies included in this systematic review, patient compliance and patient satisfaction ranged between 25.7-100% and 74-100%, respectively. Disease activity, measured by symptom severity scales and physiological biomarkers, showed improvements following telemedicine interventions in several, but not all, studies. Similar to disease activity, general and disease-specific quality of life showed improvements following telemedicine interventions in as little as 12 weeks in some studies. CONCLUSION: Telemedicine and mobile health technology may be effective in managing disease activity and improving quality of life in digestive diseases. Future studies should explore both gastrointestinal and gastroesophageal diseases using these types of interventions.
BACKGROUND: Mobile applications and interactive websites are an increasingly used method of telemedicine, but their use lacks evidence in digestive diseases. AIM: This study aims to explore digestive disease studies that use telemedicine to effectively manage disease activity, help monitor symptoms, improve compliance to the treatment protocol, increase patient satisfaction, and enhance the patient-to-provider communication. METHODS: EBSCO, PubMed, and Web of Science databases were searched using Medical Subject Headings and other keywords to identify studies that utilized telemedicine in patients with digestive disease. The PRISMA guidelines were used to identify 20 research articles that had data aligning with 4 common overlapping themes including, patient compliance (n = 13), patient satisfaction (n = 11), disease activity (n = 15), and quality of life (n = 13). The studies focused on digestive diseases including inflammatory bowel disease (n = 7), ulcerative colitis (n = 4), Crohn's Disease (n = 1), irritable bowel syndrome (n = 6), and colorectal cancer (n = 2). RESULTS: From the studies included in this systematic review, patient compliance and patient satisfaction ranged between 25.7-100% and 74-100%, respectively. Disease activity, measured by symptom severity scales and physiological biomarkers, showed improvements following telemedicine interventions in several, but not all, studies. Similar to disease activity, general and disease-specific quality of life showed improvements following telemedicine interventions in as little as 12 weeks in some studies. CONCLUSION: Telemedicine and mobile health technology may be effective in managing disease activity and improving quality of life in digestive diseases. Future studies should explore both gastrointestinal and gastroesophageal diseases using these types of interventions.
Entities:
Keywords:
Digestive system diseases; Gastrointestinal diseases; Systematic review; Telemedicine
Authors: Kevin A Hommel; Wendy N Gray; Elizabeth Hente; Katherine Loreaux; Richard F Ittenbach; Michele Maddux; Robert Baldassano; Francisco Sylvester; Wallace Crandall; Charles Doarn; Melvin B Heyman; David Keljo; Lee A Denson Journal: Contemp Clin Trials Date: 2015-05-21 Impact factor: 2.226
Authors: Raymond K Cross; Guruprasad Jambaulikar; Patricia Langenberg; J Kathleen Tracy; Joseph F Collins; Jonathan Katz; Miguel Regueiro; David A Schwartz; Charlene C Quinn Journal: Contemp Clin Trials Date: 2015-03-24 Impact factor: 2.226
Authors: Welmoed K Van Deen; Andrea E van der Meulen-de Jong; Nimisha K Parekh; Ellen Kane; Aria Zand; Courtney A DiNicola; Laurin Hall; Elizabeth K Inserra; Jennifer M Choi; Christina Y Ha; Eric Esrailian; Martijn G H van Oijen; Daniel W Hommes Journal: Clin Gastroenterol Hepatol Date: 2015-11-18 Impact factor: 11.382
Authors: Hazel Everitt; Rona Moss-Morris; Alice Sibelli; Laura Tapp; Nicholas Coleman; Lucy Yardley; Peter Smith; Paul Little Journal: BMC Gastroenterol Date: 2013-04-21 Impact factor: 3.067
Authors: Eva-Maria Messner; Niklas Sturm; Yannik Terhorst; Lasse B Sander; Dana Schultchen; Alexandra Portenhauser; Simone Schmidbaur; Michael Stach; Jochen Klaus; Harald Baumeister; Benjamin M Walter Journal: J Med Internet Res Date: 2022-10-05 Impact factor: 7.076
Authors: Andrew Lukas Yin; David Hachuel; John P Pollak; Ellen J Scherl; Deborah Estrin Journal: J Med Internet Res Date: 2019-08-19 Impact factor: 5.428
Authors: Javier Del Hoyo; Mariam Aguas; Pilar Nos; Raquel Faubel; Diana Muñoz; David Domínguez; Guillermo Bastida; Bernardo Valdivieso; Marisa Correcher Journal: J Med Internet Res Date: 2018-11-27 Impact factor: 5.428